nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—AKR1D1—testis—hypothyroidism	0.0983	0.171	CbGeAlD
Finasteride—AKR1D1—liver—hypothyroidism	0.0929	0.161	CbGeAlD
Finasteride—Drostanolone—SHBG—hypothyroidism	0.0754	0.647	CrCbGaD
Finasteride—SRD5A1—gonad—hypothyroidism	0.0728	0.126	CbGeAlD
Finasteride—SRD5A1—adrenal gland—hypothyroidism	0.0635	0.11	CbGeAlD
Finasteride—SRD5A1—testis—hypothyroidism	0.0525	0.0911	CbGeAlD
Finasteride—SRD5A1—liver—hypothyroidism	0.0496	0.0861	CbGeAlD
Finasteride—CYP3A4—urine—hypothyroidism	0.0475	0.0825	CbGeAlD
Finasteride—CYP3A7—liver—hypothyroidism	0.0269	0.0467	CbGeAlD
Finasteride—Tenderness—Liotrix—hypothyroidism	0.026	0.0896	CcSEcCtD
Finasteride—CYP3A7-CYP3A51P—liver—hypothyroidism	0.0229	0.0397	CbGeAlD
Finasteride—Progesterone—SHBG—hypothyroidism	0.0211	0.181	CrCbGaD
Finasteride—Hypotension—Liothyronine—hypothyroidism	0.0209	0.0721	CcSEcCtD
Finasteride—Testosterone—SHBG—hypothyroidism	0.02	0.171	CrCbGaD
Finasteride—Swelling—Liotrix—hypothyroidism	0.0186	0.0643	CcSEcCtD
Finasteride—Bronchitis—Liotrix—hypothyroidism	0.0137	0.0471	CcSEcCtD
Finasteride—Angioedema—Levothyroxine—hypothyroidism	0.0123	0.0424	CcSEcCtD
Finasteride—Angioedema—Dextrothyroxine—hypothyroidism	0.0123	0.0424	CcSEcCtD
Finasteride—CYP3A5—blood—hypothyroidism	0.0121	0.021	CbGeAlD
Finasteride—CYP3A5—female gonad—hypothyroidism	0.0113	0.0196	CbGeAlD
Finasteride—Dyspnoea—Dextrothyroxine—hypothyroidism	0.0098	0.0338	CcSEcCtD
Finasteride—Dyspnoea—Levothyroxine—hypothyroidism	0.0098	0.0338	CcSEcCtD
Finasteride—CYP3A5—liver—hypothyroidism	0.00947	0.0164	CbGeAlD
Finasteride—CYP3A4—blood—hypothyroidism	0.00908	0.0158	CbGeAlD
Finasteride—Angioedema—Liotrix—hypothyroidism	0.00905	0.0312	CcSEcCtD
Finasteride—Urticaria—Dextrothyroxine—hypothyroidism	0.00873	0.0301	CcSEcCtD
Finasteride—Urticaria—Levothyroxine—hypothyroidism	0.00873	0.0301	CcSEcCtD
Finasteride—Infection—Liotrix—hypothyroidism	0.00803	0.0277	CcSEcCtD
Finasteride—Asthenia—Levothyroxine—hypothyroidism	0.00789	0.0272	CcSEcCtD
Finasteride—Asthenia—Dextrothyroxine—hypothyroidism	0.00789	0.0272	CcSEcCtD
Finasteride—Pruritus—Levothyroxine—hypothyroidism	0.00778	0.0268	CcSEcCtD
Finasteride—Pruritus—Dextrothyroxine—hypothyroidism	0.00778	0.0268	CcSEcCtD
Finasteride—Hypotension—Liotrix—hypothyroidism	0.00755	0.026	CcSEcCtD
Finasteride—Dyspnoea—Liotrix—hypothyroidism	0.00721	0.0249	CcSEcCtD
Finasteride—CYP3A4—liver—hypothyroidism	0.0071	0.0123	CbGeAlD
Finasteride—Rash—Dextrothyroxine—hypothyroidism	0.00693	0.0239	CcSEcCtD
Finasteride—Rash—Levothyroxine—hypothyroidism	0.00693	0.0239	CcSEcCtD
Finasteride—Dermatitis—Dextrothyroxine—hypothyroidism	0.00692	0.0239	CcSEcCtD
Finasteride—Dermatitis—Levothyroxine—hypothyroidism	0.00692	0.0239	CcSEcCtD
Finasteride—Headache—Levothyroxine—hypothyroidism	0.00689	0.0237	CcSEcCtD
Finasteride—Headache—Dextrothyroxine—hypothyroidism	0.00689	0.0237	CcSEcCtD
Finasteride—Urticaria—Liotrix—hypothyroidism	0.00642	0.0221	CcSEcCtD
Finasteride—Hypersensitivity—Liotrix—hypothyroidism	0.00596	0.0205	CcSEcCtD
Finasteride—Asthenia—Liotrix—hypothyroidism	0.0058	0.02	CcSEcCtD
Finasteride—Pruritus—Liotrix—hypothyroidism	0.00572	0.0197	CcSEcCtD
Finasteride—Dizziness—Liotrix—hypothyroidism	0.00535	0.0184	CcSEcCtD
Finasteride—Rash—Liotrix—hypothyroidism	0.0051	0.0176	CcSEcCtD
Finasteride—Dermatitis—Liotrix—hypothyroidism	0.00509	0.0176	CcSEcCtD
Finasteride—Headache—Liotrix—hypothyroidism	0.00506	0.0175	CcSEcCtD
Finasteride—SRD5A2—Androgen biosynthesis—POMC—hypothyroidism	0.00342	0.197	CbGpPWpGaD
Finasteride—SRD5A1—Androgen biosynthesis—POMC—hypothyroidism	0.00342	0.197	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00142	0.0818	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00142	0.0818	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—IYD—hypothyroidism	0.000448	0.0258	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—IYD—hypothyroidism	0.000448	0.0258	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—IYD—hypothyroidism	0.000399	0.023	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—ATP5O—hypothyroidism	0.000381	0.0219	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—ATP5O—hypothyroidism	0.000381	0.0219	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TPO—hypothyroidism	0.000358	0.0206	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TPO—hypothyroidism	0.000358	0.0206	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—ATP5O—hypothyroidism	0.000339	0.0195	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000332	0.0191	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000332	0.0191	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TPO—hypothyroidism	0.000319	0.0184	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000296	0.017	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000166	0.00956	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TSHB—hypothyroidism	0.000166	0.00954	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TSHB—hypothyroidism	0.000166	0.00954	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TSHB—hypothyroidism	0.000148	0.0085	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PIK3C2A—hypothyroidism	0.000148	0.0085	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PIK3C2A—hypothyroidism	0.000148	0.0085	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000146	0.00839	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000146	0.00839	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000135	0.00775	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PIK3C2A—hypothyroidism	0.000132	0.00758	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.00013	0.00747	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC5A5—hypothyroidism	0.000124	0.00714	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC5A5—hypothyroidism	0.000124	0.00714	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00012	0.00691	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC5A5—hypothyroidism	0.000111	0.00636	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.74e-05	0.0056	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—IYD—hypothyroidism	8.45e-05	0.00486	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ATP5O—hypothyroidism	7.18e-05	0.00413	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—POMC—hypothyroidism	7.16e-05	0.00412	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TPO—hypothyroidism	6.75e-05	0.00388	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—POMC—hypothyroidism	6.49e-05	0.00373	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—POMC—hypothyroidism	6.49e-05	0.00373	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—IYD—hypothyroidism	6.11e-05	0.00351	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—POMC—hypothyroidism	5.79e-05	0.00333	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.59e-05	0.00321	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ATP5O—hypothyroidism	5.19e-05	0.00299	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—POMC—hypothyroidism	5.17e-05	0.00298	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TPO—hypothyroidism	4.88e-05	0.00281	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.53e-05	0.00261	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TSHB—hypothyroidism	3.13e-05	0.0018	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—IYD—hypothyroidism	2.84e-05	0.00163	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.79e-05	0.0016	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.41e-05	0.00139	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.41e-05	0.00138	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC5A5—hypothyroidism	2.34e-05	0.00135	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TPO—hypothyroidism	2.27e-05	0.00131	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TSHB—hypothyroidism	2.26e-05	0.0013	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	2.01e-05	0.00116	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.69e-05	0.000973	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—POMC—hypothyroidism	1.22e-05	0.000704	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TSHB—hypothyroidism	1.05e-05	0.000604	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	9.36e-06	0.000539	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—POMC—hypothyroidism	8.85e-06	0.000509	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.86e-06	0.000452	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—POMC—hypothyroidism	4.11e-06	0.000237	CbGpPWpGaD
